Advanced Chronic Liver Disease Clinical Trial
Official title:
Diagnosing and Monitoring Portal Hypertension Non-invasively Using Spleen Stiffness Measurement in Patients With Advanced Chronic Liver Disease: a Prospective Cohort Study
The goal of this observational study is to assess non-invasive tools' efficacy in predicting portal hypertension-related complications in individuals with advanced chronic liver disease. The main question it aims to answer are: - what are the cut-off values for non-invasive tests (NITs) (including LSM, SSM) that predict the presence and occurrence of hepatic decompensation in individuals with advanced chronic liver disease? Participants will undergo regular study visits involving non-invasive tests (LSM, SSM) and assessments to monitor hepatic decompensation over the study period.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06434753 -
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
|
Phase 3 | |
| Terminated |
NCT02034279 -
The INFECIR-2 Albumin Prevention Study
|
Phase 4 | |
| Active, not recruiting |
NCT05663944 -
REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. The RESUS Proof of Concept Study
|
Phase 2 | |
| Not yet recruiting |
NCT05602870 -
Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit
|
N/A | |
| Recruiting |
NCT04615091 -
Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery
|